# Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

> **NCT01255774** · PHASE3 · UNKNOWN · sponsor: **The New York Eye & Ear Infirmary** · enrollment: 20 (estimated)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT01255774
- **Lead sponsor:** The New York Eye & Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01255774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01255774, "Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01255774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*